Delivery Order SPE2DB22D3501-SPE2DB25FUH76

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is valued at $2,949.01 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order. The contract is for the supply of 4,565,860,584 units of Ciprofloxacin HCL 250 MG tablets, a generic antibiotic medication. The contract has a firm fixed price and an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant...
This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,578.45 firm fixed price delivery order is for the supply of 4,564,171,095 units of Ciprofloxacin HCl 500 mg tablets to support military treatment programs and facilities. This award is issued under an indefinite delivery contract (IDC) with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,049.03 Firm Fixed Price Delivery Order is for the supply of 4,566,250 units of Ciprofloxacin HCL 500 mg tablets. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $7,560.25 award is for the supply of 4,563,463,718 units of Ciprofloxacin HCL 500 mg tablets in 100-count bottles. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. This delivery order is issued under an indefinite...
This federal contract award, valued at $2,390.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,556,792 units of Ciprofloxacin HCL 250 mg tablets, with an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,549.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ciprofloxacin HCL 250 mg tablets to support military and federal healthcare programs. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
This federal contract award, valued at $1,846.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4,562,315,808 units of the drug Ciprofloxacin HCL 500 mg Tablets, which are used to treat a variety of bacterial infections. The contract has a completion date of September 27, 2023 and utilizes a Firm Fixed Price pricing type. This is a delivery order...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.38 firm fixed-price delivery order is for the supply of 4,560,762,537 units of Ciprofloxacin HCL 250 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award, valued at $2,274.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of 4,565,134,472 units of Ciprofloxacin HCL 500 mg tablets. This is a firm-fixed-price delivery order contract with a period of performance through July 15, 2024. The contract is not designated as a set-aside and was likely awarded through open competition. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUH76
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,017.84, is a delivery order for the supply of 4,567,074,482 units of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designation, indicating open competition.

Generated 5/4/25, 12:54 AM